STARBRIGHT
"STARBRIGHT" is a word mark owned by Bio-Rad Laboratories, Inc., filed at the USPTO on October 26, 2022. It is registered and covers classes 1, 5 and 42.
- Status
- Registered
- Since January 6, 2026
- Filed
- October 26, 2022
- Registered
- January 6, 2026
- Expires
- Not recorded
- Application no.
- 97649648
- Registration no.
- 8096300
- Office
- USPTO
- United States Patent and Trademark Office
- Mark type
- Word mark
- 3 classes
Who owns STARBRIGHT
The owner on file, matched to the company behind it. Every owner-name spelling for that company is grouped on its page.
Owner
Bio-Rad Laboratories, Inc.
BIO · Hercules, United States
Representative
Margaret C. McHugh
Kilpatrick Townsend & Stockton LLP
What the mark covers
The products and services STARBRIGHT is filed for, grouped by Nice class.
Fluorescent dyes for scientific or research use; fluorescent dyes for scientific use in life science applications; Dyes, stains, namely, fluorescent dyes and chemicals for labeling or staining biological cells for scientific, laboratory, or research purposes; fluorescent dyes for research use in fluorescent immunoassays (FLISA), cell-based assays, flow cytometry, and fluorescent immunohistochemical staining, and in vivo imaging; proteins for scientific and research use; cell culture proteins for scientific and research use; biochemical, namely, monoclonal antibodies for in vitro scientific and research use; biochemically labelled and enzyme labelled antibodies for use in science; microparticles containing fluorescent dyes for flow cytometry and scientific use; enzyme and chemical labelling molecules for use in science; chemicals, reagents, chemical preparations, and chemical substances all for use in analysis and testing in laboratories other than for medical or veterinary purposes; assays and reagents for use in scientific, laboratory and research purposes; immunoassays in the nature of chemical tests used to detect or quantify analytes using an immunological reaction; chemical agents for use in separation for scientific and research use; cell culture media for use in separation techniques for scientific and research use; Chemical reagent for research purposes, namely, a bioconjugation agent for conjugation and immobilization of peptides, fluorophores, biomolecules, proteins, carbohydrates, DNA/RNA or other molecules; Biochemicals for scientific, laboratory, and research use, namely, proteolytically-activatable, protease-activatable, or proteolytically activated or protease-activated immunoglobulin and antigen-binding fragments for binding to tissue, cells and antigens; biochemical test kits comprising assays and reagents for scientific, laboratory and research purposes; assay kits comprising assays and reagents for measuring, monitoring, testing and analyzing proteolytic activation and antibody binding for scientific, laboratory and research use; conjugation and labelling kits comprised primarily of reagents, antibodies, labelling enzymes and chemicals for performing conjugation and labelling reactions for use in science; reagents in kit form for performing assays for scientific and research use; flow cytometry kits comprised of research reagents, buffers and controls for research laboratory use
Fluorescent dyes and chemicals for medical use; Dyes, stains, namely, fluorescent dyes and chemicals for labeling or staining biological cells for medical purposes; proteins for medical use; cell culture proteins for medical use; monoclonal antibodies for medical use; monoclonal antibodies for in vitro medical use; fluorescent dyes for medical use in fluorescent immunoassays (FLISA), cell-based assays, flow cytometry, and fluorescent immunohistochemical staining, and in vivo imaging; biochemically labelled and enzyme labelled antibodies for medical use; microparticles containing fluorescent dyes for flow cytometry and medical use; chemical and biochemical preparations, assays, dyes, and reagents for clinical and medical laboratory use; chemical reagents for medical purposes for flow cytometry; chemicals, reagents, chemical preparations, and chemical substances all for use in analysis and testing in laboratories for medical purposes; Chemical reagent for medical purposes, namely, a bioconjugation agent for conjugation and immobilization of peptides, fluorophores, biomolecules, proteins, carbohydrates, DNA/RNA or other molecules. chemicals and chemical reagents for medical use; reagents in kit form for performing assays for medical purposes; chemicals agents for use in separation for medical use; cell culture media for use in separation techniques for medical use; biochemical test kits comprising assays and reagents for medical purposes; assay kits comprising assays and reagents for measuring, monitoring, testing and analyzing proteolytic activation and antibody binding for medical purposes; conjugation and labelling kits comprised primarily of reagents, antibodies, labelling enzymes and chemicals for performing conjugation and labelling reactions for medical purposes; flow cytometry kits comprised of research reagents, buffers and controls for medical purposes
Chemical analysis and research for others; medical laboratory services; medical testing for medical, scientific and research purposes; research and development services for others in the fields of nucleic acid, protein and antibody conjugation and modification; testing, research, design and development services in the field of biochemicals for scientific and medical research purposes; scientific and technological services, namely, custom conjugation, lateral flow assay development, lateral flow assay creation, and research and design relating to conjugate blocking technology; custom design and formulation in the nature of research, development, product evaluation of chemicals, assays and reagents for separation and purification techniques; providing technical support and consultation services relating to antibody selection and use, namely, providing technical scientific research consultation services
What has happened so far
Steps recorded by the USPTO, newest first.
- Notice of registration confirmation emailed
- Registered-principal register
- Notice of acceptance of statement of use e-mailed
- Allowed principal register - sou accepted
- Teas/email correspondence entered
- Correspondence received in law office
- Teas request for reconsideration received
- Assigned to examiner
- Notification of final refusal emailed
- Final refusal e-mailed
10 earlier steps on the official record.
About STARBRIGHT
Who owns the trademark "STARBRIGHT"?
The USPTO trademark "STARBRIGHT" (application 97649648) is owned by Bio-Rad Laboratories, Inc.
What is the status of "STARBRIGHT"?
Its status at the USPTO is: registered.
When was "STARBRIGHT" registered?
It was registered on January 6, 2026.
Get this data via the API
Everything on this page comes from the Signa API. Pull STARBRIGHT and marks like it into your own product with one request.
GET/v1/trademarks/{id}The full record: owners, classes, dates and images
GET/v1/trademarks/{id}/eventsEvery step in the office history
GET/v1/proceedings?trademark_id={id}Oppositions and cancellations against the mark
ID=tm_019d2b0d-ed96-7679-a5dd-2bc4f1b4b43b
curl https://api.signa.so/v1/trademarks/$ID \
-H "Authorization: Bearer $SIGNA_API_KEY"{
"id": "tm_019d2b0d-ed96-7679-a5dd-2bc4f1b4b43b",
"object": "trademark",
"mark_text": "STARBRIGHT",
"status": {
"primary": "active",
"stage": "registered"
},
"office_code": "US",
"application_number": "97649648",
"filing_date": "2022-10-26",
"nice_classes": [
1,
5,
42
],
"owners": [
{
"name": "Bio-Rad Laboratories, Inc.",
"entity_id": "ent_019eb6f6-e8b6-74bd-b804-5a81510f9337"
}
]
}